Following a national search, Roswell Park Comprehensive Cancer Center has appointed Marco Davila, MD, PhD, as Senior Vice President and Associate Director for Translational Research and Vice-Chair for Cellular Therapies.
Meet Lindsay Lipinski, MD, FAANS. Dr. Lipinski brings exertise in peripheral nerve tumors and entrapment neuropathies to the Roswell Park Neuro-Oncology Team.
Roswell Park Comprehensive Cancer Center Professor of Neurosurgery Michael Ciesielski, PhD, presented the most recent findings from the completed phase 2A study of the immunotherapy SurVaxM at a poster session in June at the American Society ...
First center to treat newly diagnosed glioblastoma patients as part of late-stage trial with SurVaxM
The inventors of a new and unique cancer immunotherapy developed at Roswell Park Comprehensive Cancer Center have announced a major step forward with that therapy, known as SurVaxM.